Who can use Semaglutide Semaglutide is approved for adults who have a BMI of 30 or higher, or those with a BMI of 27 or higher with at least one weight-related condition such as type 2 diabetes, high blood pressure, or high cholesterol
The injectable GLP-1 semaglutide (Ozempic) can now be dosed up to 2.0mg a week
Use a clean measuring device for each dose and keep the bulk bottle sealed and refrigerated if recommended
Instead, it reveals genetic predispositions that historically correlate with differential weight loss, glycemic control, and appetite response patterns across GLP-1 agonists
While these medications can be highly effective for weight management and metabolic health, their long-term affordability, sustainability and appropriate utilization remain key concerns. Cost and other GLP-1 coverage concerns As Hall references, employer healthcare costs already are soaring: Late last year, Mercer estimated that employers would see a 5.8% hike in healthcare costs in 2025, the third consecutive year of record-high increases
Super berries and vitamin C work together to support collagen production
